Jonas Ghouse, Helene Gellert-Kristensen, Colm J O'Rourke, Anne-Sofie Seidelin, Gudmar Thorleifsson, Gardar Sveinbjörnsson, Vinicius Tragante, Chigoziri Konkwo, Joseph Brancale, Silvia Vilarinho, Tim M Eyrich, Gustav Ahlberg, Johan S Bundgaard, Søren A Rand, Pia R Lundegaard, Erik Sørensen, Christina Mikkelsen, Jacob Træholt, Christian Erikstrup, Khoa M Dinh, Mie T Bruun, Bitten Aa Jensen, Jakob T Bay, Søren Brunak, Karina Banasik, Henrik Ullum, Triin Laisk, Reedik Mägi, Lincoln D Nadauld, Kirk U Knowlton, Stacey Knight, Lise L Gluud, Kirsten Vistisen, Einar S Björnsson, Magnus O Ulfarsson, Patrick Sulem, Hilma Holm, Ole B Pedersen, Sisse R Ostrowski, Daniel F Gudbjartsson, Thorunn Rafnar, Kari Stefansson, Ulrik Lassen, Hans-Christian Pommergaard, Jens G Hillingsø, Jesper B Andersen, Henning Bundgaard, Stefan Stender
{"title":"全基因组荟萃分析确定了9个与肝细胞癌发展高风险相关的基因座。","authors":"Jonas Ghouse, Helene Gellert-Kristensen, Colm J O'Rourke, Anne-Sofie Seidelin, Gudmar Thorleifsson, Gardar Sveinbjörnsson, Vinicius Tragante, Chigoziri Konkwo, Joseph Brancale, Silvia Vilarinho, Tim M Eyrich, Gustav Ahlberg, Johan S Bundgaard, Søren A Rand, Pia R Lundegaard, Erik Sørensen, Christina Mikkelsen, Jacob Træholt, Christian Erikstrup, Khoa M Dinh, Mie T Bruun, Bitten Aa Jensen, Jakob T Bay, Søren Brunak, Karina Banasik, Henrik Ullum, Triin Laisk, Reedik Mägi, Lincoln D Nadauld, Kirk U Knowlton, Stacey Knight, Lise L Gluud, Kirsten Vistisen, Einar S Björnsson, Magnus O Ulfarsson, Patrick Sulem, Hilma Holm, Ole B Pedersen, Sisse R Ostrowski, Daniel F Gudbjartsson, Thorunn Rafnar, Kari Stefansson, Ulrik Lassen, Hans-Christian Pommergaard, Jens G Hillingsø, Jesper B Andersen, Henning Bundgaard, Stefan Stender","doi":"10.1016/j.jhepr.2025.101485","DOIUrl":null,"url":null,"abstract":"<p><strong>Background & aims: </strong>The genetic underpinnings of hepatocellular carcinoma (HCC) remain largely unknown. Thus, we aimed to identify new genetic risk loci for HCC.</p><p><strong>Methods: </strong>We performed a genome-wide association study (GWAS) meta-analysis of 11 cohorts with validation in two independent cohorts. The identified variants were tested for effects on other hepatobiliary endpoints, and on incident HCC stratified by underlying risk factors. Mendelian randomization was used to assess the causal effects of a range of traits on the risk of HCC.</p><p><strong>Results: </strong>In meta-analyses totaling 6,540 cases and 2,096,759 controls, we identified 10 associations with HCC, of which five (in <i>KLF15</i>, <i>HSD17B13</i>, <i>APOE</i>, <i>HFE</i>, and <i>MTARC1</i>) have not previously been implicated in HCC at genome-wide statistical significance. Known associations in <i>PNPLA3</i>, <i>TM6SF2</i>, <i>TERT</i>, <i>IFNL4</i>, and <i>HLA-DP1</i> were confirmed. All associations except <i>KLF15</i> were validated in independent cohorts totaling 7,630 cases and 733,689 controls. The largest per-allele effect was seen for <i>TM6SF2</i> (beta = 0.61) followed by <i>PNPLA3</i> (0.55), <i>HFE</i> (0.45), <i>IFNL4</i> (0.31), <i>APOE</i> (0.27), <i>HSD17B13</i>, <i>HLA-DP1</i>, and <i>TERT</i> (all 0.21), and <i>MTARC1</i> (0.17). The identified variants had comparable effects on incident HCC in individuals with prevalent obesity, a high alcohol intake, diabetes, or cirrhosis. Mendelian randomization analyses confirmed the causal role of obesity in HCC. We found strong correlations between genetic effects on HCC and hepatic steatosis (r<sup>2</sup> = 0.75), and HCC and cirrhosis (r<sup>2</sup> = 0.69), whereas only three loci (<i>APOE</i>, <i>HFE</i>, and <i>TERT</i>) had concordant effects on HCC and biliary tract cancer.</p><p><strong>Conclusions: </strong>We identified and validated nine genetic variants associated with an increased risk of HCC development.</p><p><strong>Impact and implications: </strong>The genetic underpinnings of HCC remain largely unknown. In this genome-wide association meta-analysis totaling 6,540 cases with HCC and 2.1 million controls, we identified and validated nine genetic loci to associate with the risk of HCC. A deeper insight into genetic factors that affect the risk of HCC could improve our ability to predict and ultimately prevent or treat this deadly cancer.</p>","PeriodicalId":14764,"journal":{"name":"JHEP Reports","volume":"7 9","pages":"101485"},"PeriodicalIF":7.5000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12355075/pdf/","citationCount":"0","resultStr":"{\"title\":\"Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development.\",\"authors\":\"Jonas Ghouse, Helene Gellert-Kristensen, Colm J O'Rourke, Anne-Sofie Seidelin, Gudmar Thorleifsson, Gardar Sveinbjörnsson, Vinicius Tragante, Chigoziri Konkwo, Joseph Brancale, Silvia Vilarinho, Tim M Eyrich, Gustav Ahlberg, Johan S Bundgaard, Søren A Rand, Pia R Lundegaard, Erik Sørensen, Christina Mikkelsen, Jacob Træholt, Christian Erikstrup, Khoa M Dinh, Mie T Bruun, Bitten Aa Jensen, Jakob T Bay, Søren Brunak, Karina Banasik, Henrik Ullum, Triin Laisk, Reedik Mägi, Lincoln D Nadauld, Kirk U Knowlton, Stacey Knight, Lise L Gluud, Kirsten Vistisen, Einar S Björnsson, Magnus O Ulfarsson, Patrick Sulem, Hilma Holm, Ole B Pedersen, Sisse R Ostrowski, Daniel F Gudbjartsson, Thorunn Rafnar, Kari Stefansson, Ulrik Lassen, Hans-Christian Pommergaard, Jens G Hillingsø, Jesper B Andersen, Henning Bundgaard, Stefan Stender\",\"doi\":\"10.1016/j.jhepr.2025.101485\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background & aims: </strong>The genetic underpinnings of hepatocellular carcinoma (HCC) remain largely unknown. Thus, we aimed to identify new genetic risk loci for HCC.</p><p><strong>Methods: </strong>We performed a genome-wide association study (GWAS) meta-analysis of 11 cohorts with validation in two independent cohorts. The identified variants were tested for effects on other hepatobiliary endpoints, and on incident HCC stratified by underlying risk factors. Mendelian randomization was used to assess the causal effects of a range of traits on the risk of HCC.</p><p><strong>Results: </strong>In meta-analyses totaling 6,540 cases and 2,096,759 controls, we identified 10 associations with HCC, of which five (in <i>KLF15</i>, <i>HSD17B13</i>, <i>APOE</i>, <i>HFE</i>, and <i>MTARC1</i>) have not previously been implicated in HCC at genome-wide statistical significance. Known associations in <i>PNPLA3</i>, <i>TM6SF2</i>, <i>TERT</i>, <i>IFNL4</i>, and <i>HLA-DP1</i> were confirmed. All associations except <i>KLF15</i> were validated in independent cohorts totaling 7,630 cases and 733,689 controls. The largest per-allele effect was seen for <i>TM6SF2</i> (beta = 0.61) followed by <i>PNPLA3</i> (0.55), <i>HFE</i> (0.45), <i>IFNL4</i> (0.31), <i>APOE</i> (0.27), <i>HSD17B13</i>, <i>HLA-DP1</i>, and <i>TERT</i> (all 0.21), and <i>MTARC1</i> (0.17). The identified variants had comparable effects on incident HCC in individuals with prevalent obesity, a high alcohol intake, diabetes, or cirrhosis. Mendelian randomization analyses confirmed the causal role of obesity in HCC. We found strong correlations between genetic effects on HCC and hepatic steatosis (r<sup>2</sup> = 0.75), and HCC and cirrhosis (r<sup>2</sup> = 0.69), whereas only three loci (<i>APOE</i>, <i>HFE</i>, and <i>TERT</i>) had concordant effects on HCC and biliary tract cancer.</p><p><strong>Conclusions: </strong>We identified and validated nine genetic variants associated with an increased risk of HCC development.</p><p><strong>Impact and implications: </strong>The genetic underpinnings of HCC remain largely unknown. In this genome-wide association meta-analysis totaling 6,540 cases with HCC and 2.1 million controls, we identified and validated nine genetic loci to associate with the risk of HCC. A deeper insight into genetic factors that affect the risk of HCC could improve our ability to predict and ultimately prevent or treat this deadly cancer.</p>\",\"PeriodicalId\":14764,\"journal\":{\"name\":\"JHEP Reports\",\"volume\":\"7 9\",\"pages\":\"101485\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12355075/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JHEP Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhepr.2025.101485\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHEP Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhepr.2025.101485","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development.
Background & aims: The genetic underpinnings of hepatocellular carcinoma (HCC) remain largely unknown. Thus, we aimed to identify new genetic risk loci for HCC.
Methods: We performed a genome-wide association study (GWAS) meta-analysis of 11 cohorts with validation in two independent cohorts. The identified variants were tested for effects on other hepatobiliary endpoints, and on incident HCC stratified by underlying risk factors. Mendelian randomization was used to assess the causal effects of a range of traits on the risk of HCC.
Results: In meta-analyses totaling 6,540 cases and 2,096,759 controls, we identified 10 associations with HCC, of which five (in KLF15, HSD17B13, APOE, HFE, and MTARC1) have not previously been implicated in HCC at genome-wide statistical significance. Known associations in PNPLA3, TM6SF2, TERT, IFNL4, and HLA-DP1 were confirmed. All associations except KLF15 were validated in independent cohorts totaling 7,630 cases and 733,689 controls. The largest per-allele effect was seen for TM6SF2 (beta = 0.61) followed by PNPLA3 (0.55), HFE (0.45), IFNL4 (0.31), APOE (0.27), HSD17B13, HLA-DP1, and TERT (all 0.21), and MTARC1 (0.17). The identified variants had comparable effects on incident HCC in individuals with prevalent obesity, a high alcohol intake, diabetes, or cirrhosis. Mendelian randomization analyses confirmed the causal role of obesity in HCC. We found strong correlations between genetic effects on HCC and hepatic steatosis (r2 = 0.75), and HCC and cirrhosis (r2 = 0.69), whereas only three loci (APOE, HFE, and TERT) had concordant effects on HCC and biliary tract cancer.
Conclusions: We identified and validated nine genetic variants associated with an increased risk of HCC development.
Impact and implications: The genetic underpinnings of HCC remain largely unknown. In this genome-wide association meta-analysis totaling 6,540 cases with HCC and 2.1 million controls, we identified and validated nine genetic loci to associate with the risk of HCC. A deeper insight into genetic factors that affect the risk of HCC could improve our ability to predict and ultimately prevent or treat this deadly cancer.
期刊介绍：
JHEP Reports is an open access journal that is affiliated with the European Association for the Study of the Liver (EASL). It serves as a companion journal to the highly respected Journal of Hepatology.
The primary objective of JHEP Reports is to publish original papers and reviews that contribute to the advancement of knowledge in the field of liver diseases. The journal covers a wide range of topics, including basic, translational, and clinical research. It also focuses on global issues in hepatology, with particular emphasis on areas such as clinical trials, novel diagnostics, precision medicine and therapeutics, cancer research, cellular and molecular studies, artificial intelligence, microbiome research, epidemiology, and cutting-edge technologies.
In summary, JHEP Reports is dedicated to promoting scientific discoveries and innovations in liver diseases through the publication of high-quality research papers and reviews covering various aspects of hepatology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
